ACE and Alzheimer disease: Perhaps even more convincing was a report that, of 784 patients with MCI and hypertension (mean age 74 years), treatment with RAS medications (either ARBs or ACE inhibitors) was associated with a significant reduction in conversion to AD (33% vs. 40%) at 3 years, compared to other antihypertensive agents [128].